ESO Lymphoma Course
A

Current and Future Drug Development in DLBCL: Review of Methodology, Failure History & New Trial Design

By ESO Lymphoma Course FEATURING Anastasios Stathis
September 4, 2019
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Indy Hematology Review

17th Indy Hematology Review

Sat, Aug 15, 2020
Total Health Conferencing

2020 ASCO Virtual Direct™ Highlights - Jacksonville

Sat, Jul 11, 2020
See 1 other
15:50
Indy Hematology Review

Treatment Algorithm for DLBCL

Feat. J. Leonard
17:49
Jonathan Friedberg

How to Improve on RCHOP for DLBCL: Role of Novel Agents

10:46
2018 Pan Pacific Lymphoma Conference

New Approaches to Initial treatment of DLBCL: R-CHOP +

Feat. N. Bartlett
15:30
2018 Pan Pacific Lymphoma Conference

Challenges of Treating HGBCL Patients with Comorbidities: Who is "FIT" f...

Feat. L. Sehn
22:03
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Frontline Strategy for Aggressive Lymphoma - Can we Replace RCHOP?

Feat. J. Westin
12:47
2019 Scripps MD Anderson's Oncology Update

Lymphoma Practicing Changing ASCO19 Studies: Novel Agents Prior to R-Cho...

Feat. A. Saven
19:22
2018 Pan Pacific Lymphoma Conference

Challenges of Treating HGBCL Patients with Comorbidities: Anthracyclines...

Feat. L. Sehn
16:06
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Rituximab, Lenalidomide, and Ibrutinib Prior to Chemo in Newly Diagnosed...

Feat. C. Flowers
22:17
ESO Lymphoma Course

First Line DLBCL: How Many Cycles of RCHOP? Improving Outcomes of CHOP: ...

Feat. A. Davies
16:55
Laurie H. Sehn

Polatuzumab Vedotin in the Treatment of DLBCL: OS Significantly Longer w...

06:37
Cleveland Clinic's 20th Annual ASH Review

2019 ASH Review on Limited Stage DLBCL: Can We Use PET Scan to Tailor th...

Feat. B. Hill
16:44
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

How I Treat Double Hit Lymphoma

Feat. K. Dunleavy
28:25
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Does RCHOP Stay the Standard of Care After 6 Cycles in Advanced/R DLBCL?...

Feat. A. Younes
17:51
2018 Pan Pacific Lymphoma Conference

Optimum Therapy for Standard Risk High Grade - DLBCL

Feat. N. Bartlett
13:21
Daniel Persky

PET-Directed Therapy for Patients With Limited-Stage DLBCL - Results of ...

28:21
John Pagel

Treatment of Newly Diagnosed DLBCL

10:10
Northwestern Medicine Oncology and Hematology

Treatment and Management Strategies for Diffuse Large B-cell Lymphoma Di...

Feat. L. Gordon
13:26
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

The Role of Venetoclax in DLBCL: Efficacy and Safety Results from the CA...

Feat. A. Zelenetz
07:09
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Next Questions in DLBCL: New Genetic Classification Based Selection of B...

Feat. A. Younes
17:09
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

CD20-Based Bi-Specific Antibody Therapy in B-NHL: Mechanisms of Action, ...

Feat. M. Hutchings